perrin

About perrin

This author has not yet filled in any details.
So far perrin has created 33 blog entries.

Nanostics and Alberta Health Services collaborate to develop new diagnostic tools for urological diseases

2024-04-11T17:16:42+00:00
  • Nanostics and Alberta Health Services (AHS) agreement enables collaboration with AHS data scientists to develop new tools to improve the diagnosis of urological diseases.
  • This collaboration will leverage Alberta’s comprehensive digital healthcare assets to improve patient care while satisfying all AHS privacy concerns.

EDMONTON, ALBERTA – April 9th – Nanostics Inc., a precision health company developing diagnostic tests with its ClarityDX® platform technology, is excited to announce a partnership with Cancer Care Alberta, Alberta Health Services (AHS) to leverage advanced data analytics from Connect Care and the Cancer Care Alberta Data Environment for Cancer Inquiries and Decisions (DECIDe). This agreement will streamline access to Connect Care’s powerful and consolidated “one record, one patient, one health clinical information system” to help drive diagnostic and prognostic innovations in urological care in Alberta.

Click below to read the full press release.

Nanostics and Alberta Health Services collaborate to develop new diagnostic tools for urological diseases2024-04-11T17:16:42+00:00

ClarityDX Prostate Breakthrough Prostate Cancer Test

2024-01-10T22:02:48+00:00

ClarityDX Prostate is a breakthrough test that significantly advances prostate cancer screening. It provides critical support to men and their primary care providers in making more informed decisions, with 3X the accuracy, about whether a biopsy is required following a high prostate-specific antigen (PSA) test result.

ClarityDX Prostate Breakthrough Prostate Cancer Test2024-01-10T22:02:48+00:00

ClarityDX Prostate is Revolutionizing Prostate Cancer Detection

2024-01-10T22:05:14+00:00

Disruption Magazine Special Issue 21

A Better Way: How Nanostics is Revolutionizing Prostate Cancer Detection

“Any jurisdiction in the world can adopt our test. It’s got huge potential.” Nanostics Chief Commercialization Officer Colin Coros

In the realm of medical innovation, success stories often find their roots in personal journeys. Such is the case with Nanostics, a pioneering company in the field of prostate cancer diagnostics. The tale begins with Frank Sojonky, an Alberta businessman, who, upon facing a prostate cancer diagnosis, embarked on a mission to revolutionize the landscape of prostate cancer research and testing.

Sojonky’s dissatisfaction with the lack of focus on prostate cancer research in Alberta led to the creation of the Bird Dogs for Prostate Cancer Research organization in partnership with the Alberta Cancer Foundation. The organization ultimately raised more than $20 million to establish a translational research program, known as the Alberta Prostate Cancer Research Initiative, headed by CEO Dr. John Lewis. It evolved into the world’s largest repository for prostate cancer patient samples, and with a focus on translation, those samples became instrumental in developing new therapeutics and diagnostic tests.

Click below to read the full article.

ClarityDX Prostate is Revolutionizing Prostate Cancer Detection2024-01-10T22:05:14+00:00

ClarityDX Prostate: A New Way to Detect Prostate Cancer

2023-11-02T17:36:00+00:00

On November 1, 2023, CEO John Lewis presented a webinar for Prostate Cancer Foundation Canada called “ClarityDX Prostate: A New Way to Detect Prostate Cancer.”  Click on the Webinar button below to watch it!  Go to PCFC’s website here to check out the rest of their video library.

ClarityDX Prostate is an innovative blood test that marks a significant advancement in prostate cancer screening. It provides critical support to men, aged 40 to 75, and their physicians in making more informed decisions, with 3X the accuracy, about whether a biopsy is required following a high prostate-specific antigen (PSA) test result.

ClarityDX Prostate: A New Way to Detect Prostate Cancer2023-11-02T17:36:00+00:00

Nanostics Launches ClarityDX Prostate Test in Alberta to Significantly Improve Prostate Cancer Screening

2024-01-10T22:12:10+00:00

EDMONTON, ALBERTA – September 28 – Nanostics is thrilled to announce the availability of the ClarityDX Prostate test at its newly accredited clinical lab in Edmonton, Alberta. This innovative blood test marks a significant advancement in prostate cancer screening. It provides critical support to men, aged 40 to 75, and their physicians in making more informed decisions, with 3X the accuracy, about whether a biopsy is required following a high prostate-specific antigen (PSA) test result.

According to Dr. John D. Lewis, CEO of Nanostics and Bird Dogs Chair of Translational Oncology at the University of Alberta, “This test will reduce the number of unnecessary prostate biopsies, which are invasive, uncomfortable, and carry some risk.” Notably, research shows that adding ClarityDX Prostate to the patient care pathway could reduce unnecessary prostate biopsies by up to 35% and yield significant cost savings.

Click below to read the full press release.

Nanostics Launches ClarityDX Prostate Test in Alberta to Significantly Improve Prostate Cancer Screening2024-01-10T22:12:10+00:00

Nanostics is Launching ClarityDX Prostate Test in Alberta on September 28

2023-09-28T20:52:33+00:00

Join us in person to help celebrate this exciting event!

Launch Day! The official launch of our ClarityDX Prostate test in Alberta! Join us to hear from invited speakers and help celebrate this exciting milestone!

When:                  Thursday, September 28th – 4:00 pm to 4:40 pm
Where:                 Edmonton Global – Telus House – Suite 2205, 10020 100 St NW
Host:                     Malcolm Bruce, CEO Edmonton Global
Emcee:                 Reg Joseph, CEO of Health Cities
Parking:               Available in the ATB building parkade.
RSVP:                   To media@nanosticsdx.com to attend.

Nanostics is Launching ClarityDX Prostate Test in Alberta on September 282023-09-28T20:52:33+00:00

Title

Follow Us

Follow us in real-time to learn about our products and what’s in the developmental pipeline.

Contact Us

Nanostics clinical laboratory is located at 10150 102 Street, Edmonton, AB, Canada.

Hours: 9 am – 5 pm Monday to Friday

If you have questions or concerns please contact us by telephone or email. We will respond within 1 to 2 business days.

Telephone: 1-800-672-2027

  • Press 1 to connect with the Clinical Laboratory

  • Press 2 for help with ordering your ClarityDX Prostate test

  • Press 3 for General Inquiries.

Email info@nanosticsdx.com or submit a message in the Contact Us box to the right.

We value your privacy, please read our policy here: Nanostics Privacy Policy 2023

    © Copyright 2024 Nanostics | Designed by Forward Momentum | Powered by WordPress

    Go to Top